Stockreport

Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada [Canadian Business Journal (Canada)]

Theratechnologies Inc. - Common Shares  (THTX) 
PDF Addition of investigational RNA-targeted medicines build upon Theratechnologies’ foundational HIV portfolioSubmissions to Health Canada planned for 2025MONTREAL, Dec. 04 [Read more]